Cellebrite DI Balance Sheet Health

Financial Health criteria checks 6/6

Cellebrite DI has a total shareholder equity of $298.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $629.2M and $330.9M respectively. Cellebrite DI's EBIT is $56.2M making its interest coverage ratio 0.2. It has cash and short-term investments of $370.8M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio0.2x
CashUS$370.76m
EquityUS$298.32m
Total liabilitiesUS$330.93m
Total assetsUS$629.25m

Recent financial health updates

No updates

Recent updates

Cellebrite: There Are Potential Risks That Could Damper Growth

Nov 08

Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

Oct 30
Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Sep 10
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Cellebrite: Rating Downgrade As Valuation Has Caught Up

Aug 27

Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Aug 17
Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Jun 25
Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

May 21
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

Cellebrite: Big Fish In A Small Pond

Apr 29

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Nov 04
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

May 26
Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Mar 16
Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Feb 16
Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Feb 09
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Financial Position Analysis

Short Term Liabilities: CLBT's short term assets ($501.5M) exceed its short term liabilities ($272.9M).

Long Term Liabilities: CLBT's short term assets ($501.5M) exceed its long term liabilities ($58.0M).


Debt to Equity History and Analysis

Debt Level: CLBT is debt free.

Reducing Debt: CLBT has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable CLBT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: CLBT is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 30.3% per year.


Discover healthy companies